Marine Compounds and Cancer

dc.contributor.advisor	Oksuz, A.; Ozylmaz	en
dc.contributor.editor	A. Dyshlovoy, Sergey
dc.date.accessioned	2018-09-18T09:33:25Z
dc.date.accessioned	2023-07-20T09:10:22Z
dc.date.available	2018-09-18T09:33:25Z
dc.date.available	2023-07-20T09:10:22Z
dc.date.issued	2015
dc.identifier.isbn	978-3-03842-131-3
dc.identifier.uri	http://10.215.13.25/handle/123456789/2146
dc.description	In Western countries, cancer is among the most frequent causes of death. Despite striking advances in cancer therapy, there is still an urgent need for new drugs in oncology. Current development favors so called “targeted agents” or drugs that target the immune system, i.e., therapeutic antibodies that enhance or facilitate an immune response against tumor cells (also referred to as “checkpoint inhibitors”)	en
dc.language	en	en
dc.language.iso	en	en_US
dc.publisher	MDPI	en_US
dc.subject	cancer	en_US
dc.title	Marine Compounds and Cancer	en_US
dc.type	Book	en_US